Left ventricular electromechanical mapping to assess efficacy of phVEGP165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

被引:243
作者
Vale, PR
Losordo, DW
Milliken, CE
Maysky, M
Esakof, DD
Symes, JF
Isner, JM
机构
[1] St Elizabeths Med Ctr, Div Cardiol & Vasc Med, Boston, MA 02135 USA
[2] St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02135 USA
[3] St Elizabeths Med Ctr, Div Cardiothorac Surg, Boston, MA 02135 USA
[4] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
mapping; coronary disease; angiogenesis; ischemia;
D O I
10.1161/01.CIR.102.9.965
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-NOGA left ventricular (LV) electromechanical mapping (EMM) can be used to distinguish among infarcted, ischemic, and normal myocardium. We investigated the use of percutaneous LV EMM to assess the efficacy of myocardial gene transfer (GTx) of naked plasmid DNA encoding for vascular endothelial growth factor (phVEGF(165)), administered during surgery by direct myocardial injection in patients with chronic myocardial ischemia. Methods and Results-A total of 13 consecutive patients (8 men, mean age 60.1+/-2.3 years) with chronic stable angina due to angiographically documented coronary artery disease, all of whom had failed conventional therapy (drugs, PTCA, and/or CABG), were treated with direct myocardial injection of phVEGF(165) via a minithoracotomy. Foci of ischemic myocardium were identified on LV EMM by preserved viability associated with an impairment in linear local shortening, Myocardial viability, defined by mean unipolar and bipolar voltage recordings greater than or equal to 5 and greater than or equal to 2 mV, respectively, did not change significantly after GTx. Analysis of linear local shortening in areas of myocardial ischemia, however, disclosed significant improvement after (15.26+/-0.98%) versus before (9.94+/-1.53%, P = 0.004) phVEGF(165) GTx. The area of ischemic myocardium was consequently reduced from 6.45+/-1.37 cm(2) before GTx to 0.95+/-0.41 cm(2) after GTx (P = 0.001). These findings corresponded to improved perfusion scores calculated from single-photon emission CT-sestamibi myocardial perfusion scans recorded at rest (7.4+/-2.1 before GTx versus 4.5+/-1.4 after GTx, P = 0.009) and after pharmacological stress (12.8+/-2.7 before GTx versus 8.5+/-1.7 after GTx, P = 0.047). Conclusions-The results of EMM constitute objective evidence that phVEGF(165) GTx augments perfusion of ischemic myocardium. These findings, together with reduction in the size of the defects documented at rest by serial single-photon emission CT-sestamibi imaging, suggest that phVEGF(165) GTx may successfully rescue foci of hibernating myocardium.
引用
收藏
页码:965 / 974
页数:10
相关论文
共 28 条
[1]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[2]  
DILSIZIAN V, 1993, CIRCULATION, V87, P1
[3]   Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris [J].
Esakof, DD ;
Maysky, M ;
Losordo, DW ;
Vale, PR ;
Lathi, K ;
Pastore, JO ;
Symes, JF ;
Isner, JM .
HUMAN GENE THERAPY, 1999, 10 (14) :2307-2314
[4]   Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model [J].
Gepstein, L ;
Goldin, A ;
Lessick, J ;
Hayam, G ;
Shpun, S ;
Schwartz, Y ;
Hakim, G ;
Shofty, R ;
Turgeman, A ;
Kirshenbaum, D ;
Ben-Haim, SA .
CIRCULATION, 1998, 98 (19) :2055-2064
[5]  
Gepstein L, 1997, CIRCULATION, V95, P1611
[6]   Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [J].
Germano, G ;
Erel, J ;
Lewin, H ;
Kavanagh, PB ;
Berman, DS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (05) :1360-1367
[7]   Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart [J].
Giordano, FJ ;
Ping, PP ;
McKirnan, MD ;
Nozaki, S ;
DeMaria, AN ;
Dillmann, WH ;
MathieuCostello, O ;
Hammond, HK .
NATURE MEDICINE, 1996, 2 (05) :534-539
[8]   VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts [J].
Hariawala, MD ;
Horowitz, JR ;
Esakof, D ;
Sheriff, DD ;
Walter, D ;
Keyt, B ;
Isner, JM ;
Symes, JF .
JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) :77-82
[9]   Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].
Isner, JM ;
Pieczek, A ;
Schainfeld, R ;
Blair, R ;
Haley, L ;
Asahara, T ;
Rosenfield, K ;
Razvi, S ;
Walsh, E ;
Symes, JF .
LANCET, 1996, 348 (9024) :370-374
[10]   Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results [J].
Isner, JM ;
Baumgartner, I ;
Rauh, G ;
Schainfeld, R ;
Blair, R ;
Manor, O ;
Razvi, S ;
Symes, JF .
JOURNAL OF VASCULAR SURGERY, 1998, 28 (06) :964-973